•   
  •   
  •   

World Russia 'Unlikely' to Meet Promised 630M Target for COVID Vaccine Doses, Now Partnering with China

20:50  03 may  2021
20:50  03 may  2021 Source:   newsweek.com

NHL's COVID protocol-related absences for May 7, 2021

  NHL's COVID protocol-related absences for May 7, 2021 Players in the COVID protocol are: Colorado's Devan Dubnyk and Washington's Evgeny Kuznetsov.Anaheim – TBA

Russia, scrambling to meet the ambitious inoculation goals it set when it first authorized its Sputnik V vaccine, will team with Chinese manufacturers to accelerate production of the vaccine in time for its target deadlines.

a hand holding a blue umbrella: In this Dec. 10, 2020, file photo, a Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow. Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot. © Pavel Golovkin, File/AP Photo In this Dec. 10, 2020, file photo, a Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow. Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot.

A London-based science analytics company, Airfinity, told the Associated Press that it estimates Russia agreed to give 630 million doses of its homegrown vaccine to more than 100 countries but has exported only 11.5 million doses so far.

From scarcity to abundance: US faces calls to share vaccines

  From scarcity to abundance: US faces calls to share vaccines TEGUCIGALPA, Honduras (AP) — Victor Guevara knows people his age have been vaccinated against COVID-19 in many countries. His own relatives in Houston have been inoculated. But the 72-year-old Honduran lawyer, like so many others in his country, is still waiting. And increasingly, he is wondering why the United States is not doing more to help, particularly as the American vaccine supply begins to outpace demand and doses that have been approved for use elsewhere in the world, but not in the U.S., sit idle. “We live in a state of defenselessness on every level,” Guevara said of the situation in his Central American homeland.

Moscow announced three deals totaling 260 million doses with Chinese vaccine companies in the past few weeks. The doses could reach countries in Latin America, the Middle East and Africa more quickly as a result of the partnership.

The partnership is also a benefit for both Russian and Chinese interests. Rasmus Bech Hansen, founder and CEO of Airfinity, said Russia is "very ambitious and unlikely to meet their full targets."

For more reporting from the Associated Press, see below.

Earlier criticism about Russia's vaccine has been largely quieted by data published in the British medical journal The Lancet that said large-scale testing showed it to be safe, with an efficacy rate of 91%.

Yet, experts have questioned whether Russia can fulfill its pledge to countries across the world. While pledging hundreds of millions of doses, it has delivered only a fraction.

Josh joust, wing shortage, helping Canada: News from around our 50 states

  Josh joust, wing shortage, helping Canada: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

Kremlin spokesman Dmitry Peskov has said demand for Sputnik V significantly exceeds Russia's domestic production capacity.

To boost production, the Russian Direct Investment Fund (RDIF), which bankrolled Sputnik V, has signed agreements with multiple drug makers in other countries, such as India, South Korea, Brazil, Serbia, Turkey, Italy and others. There are few indications, however, that manufacturers abroad, except for those in Belarus and Kazakhstan, have made any large amounts of the vaccine so far.

RDIF declined to disclose how many doses are going to other countries. Through April 27, less than 27 million two-dose sets of Sputnik V have been reportedly produced in Russia.

The Russian Direct Investment Fund, which has been in charge of international cooperation for Sputnik V, said in April it would produce 100 million doses in collaboration with Hualan Biological Bacterin Inc., in addition to an earlier deal announced in March for 60 million doses with Shenzhen Yuanxing Gene-tech Co.

Vaccines aplenty but some Californians struggle to get one

  Vaccines aplenty but some Californians struggle to get one SAN FRANCISCO (AP) — Hearing of excess vaccine and unfilled appointments frustrates Dr. Aaron Roland, a family physician who has been lobbying for doses to inoculate his patients, many of whom are low-income, immigrants or elderly. The San Francisco Bay Area doctor has more than 200 patients who have inquired when he will offer inoculations against the coronavirus. One patient, who is 67, said he walked into a Safeway supermarket because signs said doses were available.

The two deals are in addition to a deal announced last November with Tibet Rhodiola Pharmaceutical Holding Co., which had paid $9 million to manufacture and sell the Sputnik V vaccine in China. RDIF said in April the terms of the deal were for 100 million doses with a subsidiary company belonging to Tibet Rhodiola.

In recent years, Chinese vaccine companies have turned from largely making products for use domestically to supplying the global market, with individual firms gaining WHO preapproval for specific vaccines—seen as a seal of quality. With the pandemic, Chinese vaccine companies have exported hundreds of millions of doses abroad.

Chinese vaccine makers have been quick to expand capacity and say they can meet China's domestic need by the end of the year.

"This is an acknowledgment of the Chinese vaccine manufacturers who can produce at volume," said Helen Chen, head of pharmaceuticals LEK Consulting, strategy consultancy firm in Shanghai, in an email.

However, none of the three Chinese companies have yet to start manufacturing Sputnik V.

Ballpark bargain, beef passports, concerts for the vaccinated: News from around our 50 states

  Ballpark bargain, beef passports, concerts for the vaccinated: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

Tibet Rhodiola started constructing a factory in Shanghai at the end of last year and expects production to start in September, the company said at an annual meeting for investors last month. Tibet Rhodiola Chairman Chen Dalin also said that after the successful technology transfer, they will start with an order of 80 million doses to sell back to Russia. An employee at the company declined to transfer a phone call request to the company's media department for comment.

The timeline for the newest deals are also unclear. Hualan Bio was among the 10 largest vaccines manufacturers in China in 2019. Phone calls to Hualan Bio went unanswered.

A spokeswoman for Shenzhen Yuanxing declined to say when the company will start production but said their order would not be for sale within China. RDIF had said the production will start this month.

In spite of the delays, Russia's vaccine diplomacy has made gains.

From the outset, Russia, the first country to approve a coronavirus vaccine, aimed to distribute it globally. Within weeks of giving Sputnik V regulatory approval, RDIF started actively marketing it abroad, announcing multiple deals to supply the shot to other countries. It is so far winning the "public relations" battle, analysts said in a new report examining Russia and China's vaccine diplomacy from the Economist Intelligence Unit.

Class pets, weed boom, school robots: News from around our 50 states

  Class pets, weed boom, school robots: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

"Russia has been able to build stronger diplomatic ties and in areas where it hasn't been able to," before, said Imogen Page-Jarrett, an analyst at EIU. "They have this window of opportunity while the US, E.U. and India are focusing on domestic and the rest of the world is crying out for a vaccine supply."

Newsweek, in partnership with NewsGuard, is dedicated to providing accurate and verifiable vaccine and health information. With NewsGuard's HealthGuard browser extension, users can verify if a website is a trustworthy source of health information. Visit the Newsweek VaxFacts website to learn more and to download the HealthGuard browser extension.

Related Articles

  • Trump's Failures Were the Prelude to Biden's Success | Opinion
  • Black TikTok Star Calls Activist Alyssa Milano a 'White Supremacist': 'You Can Be Better'
  • Critical Race Theory Does Not Present The U.S. As 'Evil', 1619 Project Creator Denies GOP View
  • 24 COVID Patients Die in 1 Hospital Amid India's Oxygen Shortage

Start your unlimited Newsweek trial

Vladimir Putin Calls Russia's COVID Vaccine as 'Reliable as a Kalashnikov Assault Rifle' .
The Russian president defended the Sputnik V vaccine after an annual vaccine conference named Moderna's jab the best in the world.Putin was quoted by Interfax, an independent Russian news agency, as saying the Russian vaccines "are very modern and without a doubt the most reliable and the safest today.

usr: 1
This is interesting!